• Price cuts secure NHS place for MS drugs pharmatimes
    May 15, 2018
    The National Institute for Health and Care Excellence is now backing a trio of therapies to treat relapsing remitting forms of multiple sclerosis (RRMS) after price cuts enabled the cost regulator to endorse their routine use on the NHS.
PharmaSources Customer Service